Polyunsaturated Fatty Acid Balance Modulates Microglial State in a Murine Model of Oxygen-Induced Neovascularization
<b>Background/Objectives:</b> The retina is enriched in polyunsaturated fatty acids (PUFAs) which are indispensable for normal vision, and recent clinical studies have shown that dietary supplementation of ω-6-and ω-3-polyunsaturated fatty acids (PUFAs) can provide a protective role against retinopathy of prematurity (ROP). Our study aims to understand the mechanisms by which altering ω-6-and ω-3-polyunsaturated fatty acids (PUFAs) in the eye can protect against pathologic retinal neovascularization (NV). <b>Methods:</b> We interrogated the effects of endogenous ω-3-PUFA enrichment using transgenic <i>fat-1</i> mice which convert ω-6-PUFAs to ω-3-PUFAs in the oxygen-induced retinopathy (OIR) murine model. In the OIR model, mice are exposed to 75% oxygen from postnatal day 7 (P7) to P12, then returned to room air (RA). We used a combination of immunofluorescence, bulk retinal RNA sequencing, and lipid mediator profiling by UHPLC-MS/MS in P17 mouse retinas to identify mechanisms underlying the protective effect against NV seen in <i>fat-1</i> mice exposed to OIR. <b>Results:</b><i>Fat-1</i> OIR mice were protected against the development of retinopathy, demonstrating 15.1% less vaso-obliteration (75.5% relative reduction) after OIR and a 6.1% reduction in neovascularization (71.8% relative reduction) at P17 (<i>p</i> < 0.0001 for both). We found a dampened transcriptional response to OIR in the retina of <i>fat-1</i> mice as compared to WT mouse retinas (198 vs. 782 genes, adjusted <i>p</i>-value < 0.01). Pathway analyses confirmed these findings, with significant OIR-induced transcriptional shifts in angiogenesis (adjusted <i>p</i>-value < 10<sup>-27</sup>), inflammation (adjusted <i>p</i>-value < 10<sup>-25</sup>), and microglial activation pathways (adjusted <i>p</i>-value < 10<sup>-9</sup>) in WT mouse retina that were not observed in <i>fat-1</i> mice. Enrichment scores obtained through the integration of our bulk transcriptomics data with cell-resolved retina data indicate that the protective phenotype observed in <i>fat-1</i> mice could be associated with intrinsic differences in microglia cell subtypes between WT and <i>fat-1</i> mice. In situ, WT OIR mice demonstrated an increase in Iba1+ microglia compared to WT RA mice, whereas <i>fat-1</i> OIR mice showed no difference when compared to <i>fat-1</i> RA mice. Three ARA-derived oxylipins, 12-hydroxyeicosatetraenoic acid (12-HETE), prostaglandin D2 (PGD2), and thromboxane B2 (TXB2) demonstrated a pattern of upregulation in WT OIR compared to WT RA, but no upregulation in <i>fat-1</i> OIR mice compared to <i>fat-1</i> RA. Two EPA-derived specialized pro-resolving mediators and two LA-derived oxylipins were also differentially expressed. <b>Conclusions:</b> These findings show that a lower ω-6:ω-3 protects against neovascularization and is associated with attenuation of hyperoxia-induced microglial recruitment and activation, as well as inflammation and angiogenic signaling.
Authors
- Madhuri Wadehra (ORCID: https://orcid.org/0000-0001-8514-2021)
- Brian Aguirre
- Olawande C. Olagoke (ORCID: https://orcid.org/0000-0001-9212-4948)
- Alison Chu (ORCID: https://orcid.org/0000-0003-1324-1439)
- Meng‐Chin Lin
- C. E. MARTIN
- Joanne Brown
- Cheng-Hsiang Lu
- Esther Kim
- David Casero
Institutions
- Cedars-Sinai Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- University of California, Los Angeles (US)
- Cornell University (US)
- Olive View-UCLA Medical Center (US)
- UCLA Jonsson Comprehensive Cancer Center
Publication Details
- Journal
- Nutrients
- Published
- 2026-02-26
- DOI
- https://doi.org/10.3390/nu18050749
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Eye Institute
- National Center for Advancing Translational Sciences
- David Geffen School of Medicine, University of California, Los Angeles
- Children's Discovery and Innovation Institute, University of California, Los Angeles